Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:

Stereotaxis Inc (STXS)

Stereotaxis Inc (STXS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Stereotaxis Inc. (STXS) Reports Q3 Loss, Misses Revenue Estimates Zacks - Thu Nov 10, 2022

Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of -16.67% and 2.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

STXS : 2.20 (+0.92%)
HSDT : 0.3668 (-3.47%)
Delcath Systems, Inc. (DCTH) Reports Q3 Loss, Tops Revenue Estimates Zacks - Tue Nov 8, 2022

Delcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of 12.38% and 10.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

DCTH : 3.72 (-0.27%)
STXS : 2.20 (+0.92%)
Thermo Fisher Scientific (TMO) Beats Q3 Earnings and Revenue Estimates Zacks - Wed Oct 26, 2022

Thermo Fisher (TMO) delivered earnings and revenue surprises of 6.28% and 8.30%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

TMO : 590.22 (+3.49%)
STXS : 2.20 (+0.92%)
Stereotaxis (STXS) Q2 2022 Earnings Call Transcript Motley Fool - Tue Aug 9, 2022

STXS earnings call for the period ending June 30, 2022.

STXS : 2.20 (+0.92%)
Stereotaxis Inc. (STXS) Reports Q2 Loss, Misses Revenue Estimates Zacks - Tue Aug 9, 2022

Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of -16.67% and 19.05%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

STXS : 2.20 (+0.92%)
SIEN : 2.03 (-4.25%)
Stereotaxis Reports 2022 Second Quarter Financial Results Globe Newswire - Tue Aug 9, 2022

ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.20 (+0.92%)
Orthofix (OFIX) Beats Q2 Earnings and Revenue Estimates Zacks - Fri Aug 5, 2022

Orthofix (OFIX) delivered earnings and revenue surprises of 14.29% and 0.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

OFIX : 21.59 (-0.18%)
STXS : 2.20 (+0.92%)
Nevro (NVRO) Reports Q2 Loss, Misses Revenue Estimates Zacks - Wed Aug 3, 2022

Nevro (NVRO) delivered earnings and revenue surprises of 12.35% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

NVRO : 36.89 (+0.46%)
STXS : 2.20 (+0.92%)
Veracyte (VCYT) Reports Q2 Loss, Tops Revenue Estimates Zacks - Tue Aug 2, 2022

Veracyte (VCYT) delivered earnings and revenue surprises of 38.10% and 8.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

VCYT : 25.73 (+2.39%)
STXS : 2.20 (+0.92%)
Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline Globe Newswire - Tue Aug 2, 2022

ST. LOUIS, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive...

STXS : 2.20 (+0.92%)

Barchart Exclusives

2 Reasons Foot Locker Is a Retailer to Watch in 2023 Barchart - 42 minutes ago
Credit Suisse analyst Michael Binetti upgraded Foot Locker stock on Wednesday from Neutral to Outperform. More importantly, the analyst raised his target price by more than 60% to $62, 38% higher than where it’s currently trading.    Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot